Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-23T04:34:17.088Z Has data issue: false hasContentIssue false
  • English
  • Français

Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia

Published online by Cambridge University Press:  09 July 2009

John L. Waddington  and
Hanafy A. Youssef
John L. Waddington*
Affiliation:
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin; St Davnet's Hospital, Monaghan, Ireland
Hanafy A. Youssef
Affiliation:
Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin; St Davnet's Hospital, Monaghan, Ireland
*
1Address for correspondence: Professor John L. Waddington, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, St. Stephen's Green, Dublin 2, Ireland
Get access Rights & Permissions [Opens in a new window]

Synopsis

Basic cognitive function was assessed at initial and at 5- and 10-year follow-up assessments among 41 primarily middle-aged in-patients manifesting the severest form of schizophrenia; additionally, the presence and severity of tardive dyskinesia was evaluated on each occasion. Overall, there was a modest but significant deterioration in cognitive function over the decade, particularly among older men. Longitudinally, patients with persistent tardive (orofacial) dyskinesia continued to show poorer cognitive function than those consistently without such movement disorder, though within neither group did cognitive function change over the decade. Those patients demonstrating prospectively the emergence of orofacial dyskinesia showed a marked deterioration in their cognitive function over the same time-frame within which their movement disorder emerged, but this decline did not progress further thereafter. There appears to exist some modest, progressive deterioration in cognitive function even late in the chronic phase of severe schizophrenic illness which appears to derive primarily from patients showing de novo emergence of tardive orofacial dyskinesia.

Type
Original Articles
Information
Psychological Medicine , Volume 26 , Issue 4 , July 1996 , pp. 681 - 688
Copyright
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Barnes, T. R. E. (1990). Movement disorder associated with antipsychotic drugs: the tardive syndromes. International Review of Psychiatry 2, 243–254.CrossRefGoogle Scholar
Bilder, R. M., Lipschutz-Broch, L., Reiter, G., Geisler, S. H., Mayerhoff, D. I. & Lieberman, J. A. (1992). Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophrenia Bulletin 18, 437–448.CrossRefGoogle ScholarPubMed
Blanchard, J. J. & Neale, J. M. (1994). The neuropsychological signature of schizophrenia: generalized or differential deficit? American Journal of Psychiatry 151, 40–48.Google ScholarPubMed
Buckwalter, J. G., Sobel, E., Dunn, M. E., Diz, M. M. & Henderson, V. W. (1993). Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Archives of Neurology 50, 757–760.CrossRefGoogle ScholarPubMed
Buhrich, N., Crow, T. J., Johnstone, E. C. & Owens, D. G. C. (1988). Age disorientation in chronic schizophrenia is not associated with premorbid intellectual impairment or past physical treatment. British Journal of Psychiatry 152, 466–469.CrossRefGoogle ScholarPubMed
Casanova, M. F., Carosella, N. W., Gold, J. M., Kleinman, J. E., Weinberger, D. R. & Powers, R. E. (1992). A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Research 49, 41–62.CrossRefGoogle Scholar
Davis, J. M. (1976). Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 33, 858–861.CrossRefGoogle ScholarPubMed
Edwards, H. (1970). The significance of brain damage in persistent oral dyskinesia. British Journal of Psychiatry 116, 271–275.CrossRefGoogle ScholarPubMed
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G. & Munoz, R. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 57–63.CrossRefGoogle ScholarPubMed
Fenton, W. S., Wyatt, R. J. & McGlashan, T. H. (1994). Risk factors for spontaneous dyskinesia in schizophrenia. Archives of General Psychiatry 51, 643–650.CrossRefGoogle ScholarPubMed
Goldberg, T. E., Hyde, T. M., Kleinman, J. E. & Weinberger, D. R. (1993). Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophrenia Bulletin 19, 797–804.CrossRefGoogle ScholarPubMed
Goldstein, J. M. (1988). Gender differences in the course of schizophrenia. American Journal of Psychiatry 145, 684–689.Google ScholarPubMed
Haroutunian, V., Davidson, M., Kanof, P. D., Perl, D. P., Powchik, P., Losonczy, M., McCrystal, J., Purohit, D. P., Bierer, L. M. & Davis, K. (1994). Cortical cholinergic markers in schizophrenia. Schizophrenia Research 12, 137–144.CrossRefGoogle ScholarPubMed
Heaton, R. K. & Drexler, M. (1987). Clinical neuropsychological findings in schizophrenia and aging. In Schizophrenia and Aging (ed. Miller, N. E. and Cohen, G. D.), pp. 145–161. Guilford Press: New York.Google Scholar
Heaton, R., Paulsen, J. S., McAdams, L. A., Kuck, J., Zisook, S., Braff, D., Harris, M. J. & Jeste, D. V. (1994). Neuropsychological deficits in schizophrenics: relationship to age, chronicity and dementia. Archives of General Psychiatry 51, 469–476.CrossRefGoogle ScholarPubMed
Hoff, A. L., Riordan, H., O'Donnell, D. W., Morris, L. & DeLisi, L. E. (1992). Neuropsychological functioning in first episode schizophreniform patients. American Journal of Psychiatry 149, 898–903.Google ScholarPubMed
Hyde, T. M., Nawroz, S., Goldberg, T. E., Bigelow, L. B., Strong, D., Ostrem, J. L., Weinberger, D. R. & Kleinman, J. E. (1994). Is there cognitive decline in schizophrenia? A cross-sectional study. British Journal of Psychiatry 164, 494–500.CrossRefGoogle ScholarPubMed
Kraepelin, E. (1919). Dementia Praecox and Paraphrenia (translated by Barclay, R. M.). Robert E. Kreiger: New York. (1971).Google Scholar
National Institute of Mental Health (1976). Abnormal involuntary movement scale. In ECDEU Assessment Manual (ed. Guy, W.), pp. 534–537. US Department of Health, Education and Welfare: Rockville.Google Scholar
Owens, D. G. C., Johnstone, E. C. & Frith, C. D. (1982). Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Archives of General Psychiatry 39, 452–461.CrossRefGoogle ScholarPubMed
Purohit, D. P., Davidson, M., Perl, D. P., Powchik, P., Haroutunian, V. H., Bierer, L. M., McCrystal, J., Losonczy, M. & Davis, K. L. (1993). Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biological Psychiatry 33, 255–260.CrossRefGoogle ScholarPubMed
Rogers, D. (1985). The motor disorders of severe psychiatric illness: the conflict of paradigms. British Journal of Psychiatry 47, 221–232.CrossRefGoogle Scholar
Saykin, A. J., Shtasel, D. L., Gur, R. E., Kester, D. B., Mozley, L. H., Stafinak, P. & Gur, R. C. (1994). Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry 51, 124–131.CrossRefGoogle ScholarPubMed
Shtasel, D. L., Gur, R. E., Gallacher, F., Heimberg, C. & Gur, R. C. (1992). Gender differences in the clinical expression of schizophrenia. Schizophrenia Research 7, 225–231.CrossRefGoogle ScholarPubMed
Stern, R. G., Mohs, R. C., Davidson, M., Schmeidler, J., Silverman, J., Kramer-Ginsberg, E., Searcey, T., Bierer, L. & Davis, K. L. (1994). A longitudinal study of Alzheimer's disease: measurement, rate and predictors of cognitive deterioration. American Journal of Psychiatry 151, 390–396.Google ScholarPubMed
Waddington, J. L. (1989). Schizophrenia, affective psychoses and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants and the conflict of paradigms. International Review of Neurobiology 31, 297–353.CrossRefGoogle ScholarPubMed
Waddington, J. L. (1993 a). Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531–536.CrossRefGoogle ScholarPubMed
Waddington, J. L. (1993 b). Neurodynamics of abnormalities in cerebral metabolism and structure in schizophrenia. Schizophrenia Bulletin 19, 55–69.CrossRefGoogle ScholarPubMed
Waddington, J. L. (1995). Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs. In Behavioral Neurology of Movement Disorders (ed. Weiner, W. J. and Lang, A. E.), pp. 211–229. Raven Press: New York.Google Scholar
Waddington, J. L. & Youssef, H. A. (1986). An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms. American Journal of Psychiatry 143, 1162–1165.Google ScholarPubMed
Waddington, J. L., Youssef, H. A., Dolphin, C. & Kinsella, A. (1987). Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia: their association in relation to topography of involuntary movements and criterion of their abnormality. Archives of General Psychiatry 44, 907–912.CrossRefGoogle ScholarPubMed
Waddington, J. L., Youssef, H. A. & Kinsella, A. (1990). Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine 20, 835–842.CrossRefGoogle Scholar
Waddington, J. L., O'Callaghan, E., Larkin, C. & Kinsella, A. (1993). Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia? Brain and Cognition 23, 56–70.CrossRefGoogle ScholarPubMed
Waddington, J. L., Youssef, H. A. & Kinsella, A. (1995 a). Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychological Medicine 25, 849–857.CrossRefGoogle ScholarPubMed
Waddington, J. L., O'Callaghan, E., Buckley, P., Madigan, C., Redmond, O., Stack, J. P., Kinsella, A., Larkin, C. & Ennis, J. T. (1995 b). Tardive dyskinesia in schizophrenia: relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging. British Journal of Psychiatry 167, 41–44.CrossRefGoogle ScholarPubMed